05 Nov 2018 --- Maritech fucoidan – a bioactive compound extracted from seaweed – can inhibit the production of key pro-inflammatory biomarkers that are clinically relevant in acute and chronic gut condition, new research has found. Maritech fucoidan ingredients are extracted from wild Undaria pinnatifida and Fucus vesiculosus macroalgae by Australian biotechnology company Marinova.
